Homocysteine thiolactone and H2O2 induce amino acid modifications and alter the fibrillation propensity of the Aβ25–35 peptide

Of the proteinaceous β‐sheet‐rich amyloid fibrillar structures, the Aβ25–35 peptide, a component of the full‐length Aβ involved in Alzheimer's disease, has similar toxicity to the parent peptide. In this study, the effects of homocysteine thiolactone (HCTL) and hydrogen peroxide (H2O2) on the conformation and fibrillation propensity of the Aβ25–35 peptide were investigated. Both HCTL and H2O2 induced amino acid modifications along with alteration in aggregation propensity. Methionine (Met)‐35 was oxidized by H2O2 and aggregation was attenuated following the increased hydrophilicity of the peptide due to sulfoxide/sulfone formation. The HCTL‐modified lysine (Lys‐28) residue destabilizes the structure of the peptide, which leads to fibrillation. Our studies provide important information regarding the relationship between amino acid modifications and the amyloid fibrillation process.

[1]  Bryan M. Delfing,et al.  Met35 Oxidation Hinders Aβ25-35 Peptide Aggregation within the Dimyristoylphosphatidylcholine Bilayer. , 2021, ACS chemical neuroscience.

[2]  S. Dasgupta,et al.  Gallic acid induced dose dependent inhibition of lysozyme fibrillation. , 2017, International journal of biological macromolecules.

[3]  J. Carver,et al.  Measurement of amyloid formation by turbidity assay—seeing through the cloud , 2016, Biophysical Reviews.

[4]  S. Dasgupta,et al.  Hydropathy: the controlling factor behind the inhibition of Aβ fibrillation by graphene oxide , 2016 .

[5]  S. Dasgupta,et al.  Hydrophobic tail length plays a pivotal role in amyloid beta (25–35) fibril–surfactant interactions , 2016, Proteins.

[6]  Ann Tiiman,et al.  Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide , 2015, Biochemistry and biophysics reports.

[7]  G. S. Sharma,et al.  N-Homocysteinylation Induces Different Structural and Functional Consequences on Acidic and Basic Proteins , 2014, PloS one.

[8]  A. Moosavi-Movahedi,et al.  Effect of homocysteinylation on structure, chaperone activity and fibrillation propensity of lens alpha-crystallin. , 2013, Protein and peptide letters.

[9]  S. Hornemann,et al.  Multiple Substitutions of Methionine 129 in Human Prion Protein Reveal Its Importance in the Amyloid Fibrillation Pathway* , 2012, The Journal of Biological Chemistry.

[10]  A. Moosavi-Movahedi,et al.  Effect of Homocysteine Thiolactone on Structure and Aggregation Propensity of Bovine Pancreatic Insulin , 2011, The protein journal.

[11]  A. Oliveira‐Brett,et al.  Boron doped diamond and glassy carbon electrodes comparative study of the oxidation behaviour of cysteine and methionine. , 2011, Bioelectrochemistry.

[12]  D. Butterfield,et al.  Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories , 2011, NeuroMolecular Medicine.

[13]  F. Sbrana,et al.  Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. , 2010, Journal of molecular biology.

[14]  V. Andrisano,et al.  Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity. , 2008, Journal of medicinal chemistry.

[15]  D. Jacobsen,et al.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. , 2007, Antioxidants & redox signaling.

[16]  H. Jakubowski,et al.  Modification by homocysteine thiolactone affects redox status of cytochrome C. , 2007, Biochemistry.

[17]  H. Jakubowski Pathophysiological consequences of homocysteine excess. , 2006, The Journal of nutrition.

[18]  M. Warren,et al.  Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. , 2006, Biochemistry.

[19]  Knut Engedal,et al.  Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study , 2005, Annals of neurology.

[20]  C. Schöneich Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. , 2005, Biochimica et biophysica acta.

[21]  J. Kelly,et al.  Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. , 2003, Biochemistry.

[22]  S. Dante,et al.  Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extents. , 2002, Biophysical journal.

[23]  I. Kang,et al.  Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's Disease* , 2002, The Journal of Biological Chemistry.

[24]  C. Riener,et al.  Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4′-dithiodipyridine , 2002, Analytical and bioanalytical chemistry.

[25]  Magnus Palmblad,et al.  Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers* , 2002, The Journal of Biological Chemistry.

[26]  V. Sánchez-Margalet,et al.  Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. , 2001, Journal of molecular endocrinology.

[27]  M. Staufenbiel,et al.  Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.

[28]  D. Butterfield,et al.  Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.

[29]  J. Sipe,et al.  Review: history of the amyloid fibril. , 2000, Journal of structural biology.

[30]  H. Jakubowski Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  W. Markesbery,et al.  Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain , 1999, Journal of neurochemistry.

[32]  D. Butterfield,et al.  Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress , 1999, Brain Research Bulletin.

[33]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[34]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[35]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[36]  D. Craik,et al.  Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? , 1998, Biochemistry.

[37]  H. Jakubowski Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. , 1997, The Journal of biological chemistry.

[38]  K. Imahori,et al.  Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution. , 1995, Journal of biochemistry.

[39]  J. Valk,et al.  Hyperhomocysteinaemia; with reference to its neuroradiological aspects , 1995, Neuroradiology.

[40]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[41]  T. Holzman,et al.  Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.

[42]  R. Martins,et al.  Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress , 1986, Journal of neurochemistry.

[43]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[44]  K. Bailey,et al.  The X-ray interpretation of denaturation and the structure of the seed globulins. , 1935, The Biochemical journal.

[45]  A. Rego,et al.  Protective effect of zinc on amyloid-ß 25–35 and 1–40 mediated toxicity , 2009, Neurotoxicity Research.

[46]  E. Porcellini,et al.  Homocysteine and folate as risk factors for dementia and Alzheimer disease. , 2005, The American journal of clinical nutrition.

[47]  C. J. McGrath,et al.  Effect of exchange rate return on volatility spill-over across trading regions , 2012 .

[48]  W. Vogt Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.